Obesity is a chronic, biologic disease, and different patients need different tools
Noom goes one step further with its SmartDose program, a highly personalized, "low and slow" titration method that effectively doubles the number of dose steps and includes more frequent check-ins than the standard protocol
Tirzepatide treatment was not associated with excess cardiovascular risk (54, 74)
Opiates Exendin-4 and liraglutide reduced cue- and drug-induced opiate-seeking behavior in rats and mice across several studies 83,84,85,86,87,88
Yes, short-acting GLP-1 medications like exenatide (Byetta) with a 2.4-hour half-life clear within 1224 hours, while long-acting formulations can take 410 weeks to fully eliminate
While the inherent pharmacokinetic properties of each GLP-1 receptor agonist largely determine elimination time, several patient-specific factors can influence how quickly or slowly these medications clear from the body